{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T16:20:25Z","timestamp":1786119625763,"version":"build-2736575974"},"reference-count":46,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2011,4]]},"DOI":"10.1097\/phm.0b013e31820636fd","type":"journal-article","created":{"date-parts":[[2011,3,5]],"date-time":"2011-03-05T12:20:23Z","timestamp":1299327623000},"page":"321-329","source":"Crossref","is-referenced-by-count":22,"title":["Botulinum Toxin Type B in the Treatment of Residual Limb Hyperhidrosis for Lower Limb Amputees"],"prefix":"10.1097","volume":"90","author":[{"given":"Uwe","family":"Kern","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthias","family":"Kohl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ulrich","family":"Seifert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tanja","family":"Schlereth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-9-20210202","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1080\/000155500750043140","article-title":"Botulinum toxin A for focal hyperhidrosis in leg amputees: a case report.","volume":"80","author":"Wollina","year":"2000","journal-title":"Acta Derm Venereol"},{"key":"R2-9-20210202","doi-asserted-by":"crossref","first-page":"1286","DOI":"10.1053\/apmr.2001.25154","article-title":"Hygiene problems of residual limb and silicone liners in transtibial amputees wearing the total surface bearing socket.","volume":"82","author":"Hachisuka","year":"2001","journal-title":"Arch Phys Med Rehabil"},{"key":"R3-9-20210202","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1053\/hanthe.2002.v15.01562","article-title":"A survey of the satisfaction of upper limb amputees with their prostheses, their lifestyles, and their abilities.","volume":"15","author":"Davidson","year":"2002","journal-title":"J Hand Ther"},{"key":"R4-9-20210202","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1080\/03093640108726601","article-title":"Consequences of non-vascular trans-femoral amputation: a survey of quality of life, prosthetic use and problems.","volume":"25","author":"Hagberg","year":"2001","journal-title":"Prosthet Orthot Int"},{"key":"R5-9-20210202","doi-asserted-by":"crossref","first-page":"966","DOI":"10.1097\/00007611-195808000-00005","article-title":"Chemical control of hyperhidrosis of amputation stumps.","volume":"51","author":"Vultee","year":"1958","journal-title":"South Med J"},{"key":"R6-9-20210202","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1007\/s00482-009-0786-5","article-title":"Prevalence and risk factors of phantom limb pain and phantom limb sensations in Germany. A nationwide field survey.","volume":"23","author":"Kern","year":"2009","journal-title":"Schmerz"},{"key":"R7-9-20210202","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1097\/00002060-200108000-00003","article-title":"Use and satisfaction with prosthetic devices among persons with trauma-related amputations: a long-term outcome study.","volume":"80","author":"Dillingham","year":"2001","journal-title":"Am J Phys Med Rehabil"},{"key":"R8-9-20210202","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1080\/16501970410029771","article-title":"Does botulinum toxin A make prosthesis use easier for amputees?","volume":"36","author":"Kern","year":"2004","journal-title":"J Rehabil Med"},{"key":"R9-9-20210202","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.1016\/j.apmr.2007.11.054","article-title":"Intradermal botulinum toxin type A injection effectively reduces residual limb hyperhidrosis in amputees: a case series.","volume":"89","author":"Charrow","year":"2008","journal-title":"Arch Phys Med Rehabil"},{"key":"R10-9-20210202","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1159\/000067023","article-title":"Autonomic side effects of botulinum toxin type B treatment of cervical dystonia and hyperhidrosis.","volume":"49","author":"Dressler","year":"2003","journal-title":"Eur Neurol"},{"key":"R11-9-20210202","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1097\/00042728-200503000-00002","article-title":"Double-blind, randomized, placebo-controlled pilot study of the safety and efficacy of Myobloc (botulinum toxin type B) for the treatment of palmar hyperhidrosis.","volume":"31","author":"Baumann","year":"2005","journal-title":"Dermatol Surg"},{"key":"R12-9-20210202","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1007\/s00403-003-0440-5","article-title":"Successful treatment of axillary hyperhidrosis with very low doses of botulinum toxin B: a pilot study.","volume":"295","author":"Hecht","year":"2004","journal-title":"Arch Dermatol Res"},{"key":"R13-9-20210202","first-page":"302","article-title":"Ein neues Verfahren zu der klinischen Untersuchung der Schweissabsonderung.","volume":"101","author":"Minor","year":"1927","journal-title":"Z Neurologie"},{"key":"R14-9-20210202","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1002\/1531-8257(200001)15:1<146::AID-MDS1023>3.0.CO;2-X","article-title":"Sudomotor testing discriminates between subjects with and without antibodies against botulinum toxin A-a preliminary observation.","volume":"15","author":"Birklein","year":"2000","journal-title":"Mov Disord"},{"key":"R16-9-20210202","first-page":"32","article-title":"Hyperhidrosis-causes and treatment of enhanced sweating.","volume":"106","author":"Schlereth","year":"2009","journal-title":"Dtsch Arztebl Int"},{"key":"R17-9-20210202","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1093\/ptj\/84.3.262","article-title":"Management of postsurgical hyperhidrosis with direct current and tap water.","volume":"84","author":"Gillick","year":"2004","journal-title":"Phys Ther"},{"key":"R18-9-20210202","first-page":"1401","article-title":"Letter: stump hyperhidrosis in a leg amputee: treatment with botulinum toxin A.","volume":"33","author":"Garcia-Morales","year":"2007","journal-title":"Dermatol Surg"},{"key":"R19-9-20210202","first-page":"73","article-title":"A study on the development and the deodorizing capability of metal-phthalocyanine processed stump socks for amputees.","volume":"46","author":"Furukawa","year":"2000","journal-title":"Kobe J Med Sci"},{"key":"R20-9-20210202","doi-asserted-by":"crossref","first-page":"172","DOI":"10.3109\/03093649609164439","article-title":"The use of Methenamine as an antiperspirant for amputees.","volume":"20","author":"Susak","year":"1996","journal-title":"Prosthet Orthot Int"},{"key":"R21-9-20210202","first-page":"50","article-title":"Effect of botulinum toxin type A on the expression of substance P, calcitonin gene-related peptide, transforming growth factor beta-1 and alpha smooth muscle actin A in wound healing in rats.","volume":"25","author":"Wang","year":"2009","journal-title":"Zhonghua Zheng Xing Wai Ke Za Zhi"},{"issue":"pt 3","key":"R22-9-20210202","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1113\/jphysiol.2006.116111","article-title":"Peripheral amplification of sweating-a role for calcitonin gene-related peptide.","volume":"576","author":"Schlereth","year":"2006","journal-title":"J Physiol"},{"key":"R23-9-20210202","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.coph.2008.12.007","article-title":"CGRP receptors in the control of pain and inflammation.","volume":"9","author":"Benemei","year":"2009","journal-title":"Curr Opin Pharmacol"},{"key":"R24-9-20210202","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1097\/00002060-200603000-00136","article-title":"Poster board 52: botulinum toxin type A for hyperhidrosis of the residual limb: a case report.","volume":"85","author":"Poluri","year":"2006","journal-title":"Am J Phys Med Rehabil"},{"issue":"suppl 4","key":"R25-9-20210202","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1111\/j.1468-1331.1999.tb00029.x","article-title":"Botulinum toxin type A: new therapeutic directions.","volume":"6","author":"Guyer","year":"1999","journal-title":"Eur J Neurol"},{"key":"R26-9-20210202","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1097\/01.PHM.0000124444.32257.04","article-title":"Effects of botulinum toxin type B on stump pain and involuntary movements of the stump.","volume":"83","author":"Kern","year":"2004","journal-title":"Am J Phys Med Rehabil"},{"key":"R27-9-20210202","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/S0304-3959(01)00466-3","article-title":"Sympathetic nerve activity to amputated lower leg in humans. Evidence of altered skin vasoconstrictor discharge.","volume":"98","author":"Fagius","year":"2002","journal-title":"Pain"},{"key":"R28-9-20210202","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1212\/WNL.49.3.701","article-title":"Botulinum toxin type B: a double-blind, placebo-controlled, safety and efficacy study in cervical dystonia.","volume":"49","author":"Lew","year":"1997","journal-title":"Neurology"},{"key":"R29-9-20210202","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1007\/s10286-003-0118-2","article-title":"Botulism type B presenting as pure autonomic dysfunction.","volume":"13","author":"Merz","year":"2003","journal-title":"Clin Auton Res"},{"key":"R30-9-20210202","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1111\/j.1365-4632.2004.02531.x","article-title":"Pilot study of the safety and efficacy of Myobloc (botulinum toxin type B) for treatment of axillary hyperhidrosis.","volume":"44","author":"Baumann","year":"2005","journal-title":"Int J Dermatol"},{"key":"R31-9-20210202","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1002\/mus.21213","article-title":"Randomized double-blind study of botulinum toxin type B for sialorrhea in ALS patients.","volume":"39","author":"Jackson","year":"2009","journal-title":"Muscle Nerve"},{"key":"R32-9-20210202","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/j.autneu.2004.11.005","article-title":"Botulinum toxin A (Botox) and sweating-dose efficacy and comparison to other BoNT preparations.","volume":"117","author":"Schlereth","year":"2005","journal-title":"Auton Neurosci"},{"key":"R33-9-20210202","doi-asserted-by":"crossref","first-page":"229","DOI":"10.2340\/00015555-0419","article-title":"Anhidrotic effect of intradermal injections of botulinum toxin: a comparison of different products and concentrations.","volume":"88","author":"Rystedt","year":"2008","journal-title":"Acta Derm Venereol"},{"key":"R36-9-20210202","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1002\/mds.21724","article-title":"Botulinum toxin type B vs. type A in toxin-naive patients with cervical dystonia: randomized, double-blind, noninferiority trial.","volume":"23","author":"Pappert","year":"2008","journal-title":"Mov Disord"},{"key":"R37-9-20210202","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1212\/01.wnl.0000174433.76707.8c","article-title":"Autonomic function after botulinum toxin type A or B: a double-blind, randomized trial.","volume":"65","author":"Tintner","year":"2005","journal-title":"Neurology"},{"key":"R38-9-20210202","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1007\/s001050051236","article-title":"Botulinum toxin. A neurotoxin for dermatologic therapy.","volume":"51","author":"Breit","year":"2000","journal-title":"Hautarzt"},{"key":"R39-9-20210202","doi-asserted-by":"crossref","first-page":"1312","DOI":"10.1046\/j.1523-1747.2003.12620.x","article-title":"Botulinum toxin type B blocks sudomotor function effectively: a 6 month follow up.","volume":"121","author":"Birklein","year":"2003","journal-title":"J Invest Dermatol"},{"issue":"suppl 1","key":"R40-9-20210202","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1007\/PL00007817","article-title":"Evidence-based medicine: botulinum toxin in focal hyperhidrosis.","volume":"248","author":"Naumann","year":"2001","journal-title":"J Neurol"},{"key":"R41-9-20210202","doi-asserted-by":"crossref","first-page":"1439","DOI":"10.1212\/WNL.53.7.1439","article-title":"Safety and efficacy of NeuroBloc (botulinum toxin type B) in type A-responsive cervical dystonia.","volume":"53","author":"Brashear","year":"1999","journal-title":"Neurology"},{"key":"R42-9-20210202","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.pain.2004.03.013","article-title":"Neuroelectric source imaging of steady-state movement-related cortical potentials in human upper extremity amputees with and without phantom limb pain.","volume":"110","author":"Karl","year":"2004","journal-title":"Pain"},{"key":"R44-9-20210202","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1007\/s00482-003-0202-5","article-title":"Treatment of phantom pain with botulinum-toxin A. A pilot study.","volume":"17","author":"Kern","year":"2003","journal-title":"Schmerz"},{"key":"R45-9-20210202","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1007\/s00115-003-1657-4","article-title":"Long-term treatment of phantom- and stump pain with botulinum toxin type A over 12 months. A first clinical observation.","volume":"75","author":"Kern","year":"2004","journal-title":"Nervenarzt"},{"key":"R46-9-20210202","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1111\/j.1526-4637.2008.00554.x","article-title":"Treatment of phantom limb pain with botulinum toxin type A.","volume":"10","author":"Jin","year":"2009","journal-title":"Pain Med"},{"key":"R47-9-20210202","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.pain.2006.10.030","article-title":"Botulinum toxin type A reduces capsaicin-evoked pain and neurogenic vasodilatation in human skin.","volume":"130","author":"Tugnoli","year":"2007","journal-title":"Pain"},{"key":"R48-9-20210202","doi-asserted-by":"crossref","first-page":"1823","DOI":"10.1097\/01.prs.0000287135.17291.2f","article-title":"The effects of botulinum toxin type A on muscle blood perfusion and metabolism.","volume":"120","author":"Matic","year":"2007","journal-title":"Plast Reconstr Surg"},{"key":"R49-9-20210202","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1007\/s11552-009-9169-8","article-title":"Modification of blood vessel diameter following perivascular application of botulinum toxin-A.","volume":"4","author":"Arnold","year":"2009","journal-title":"Hand (NY)"},{"key":"R50-9-20210202","first-page":"227","article-title":"Prevalence and characteristics of chronic phantom limb pain among American veterans. Results of a trial survey.","volume":"62","author":"Sherman","year":"1983","journal-title":"Am J Phys Med"}],"container-title":["American Journal of Physical Medicine &amp; Rehabilitation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/00002060-201104000-00009","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T18:46:30Z","timestamp":1786041990000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00002060-201104000-00009"}},"subtitle":["A Pilot Study"],"short-title":[],"issued":{"date-parts":[[2011,4]]},"references-count":46,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2011]]}},"URL":"https:\/\/doi.org\/10.1097\/phm.0b013e31820636fd","relation":{},"ISSN":["0894-9115"],"issn-type":[{"value":"0894-9115","type":"print"}],"subject":[],"published":{"date-parts":[[2011,4]]}}}